159 related articles for article (PubMed ID: 35042454)
21. Effects of Metabolic Syndrome and Its Components on the Prognosis of Endometrial Cancer.
Yang X; Li X; Dong Y; Fan Y; Cheng Y; Zhai L; Zhang S; Zhou J; Wang J
Front Endocrinol (Lausanne); 2021; 12():780769. PubMed ID: 34975754
[TBL] [Abstract][Full Text] [Related]
22. Upregulated delta-like protein 3 expression is a diagnostic and prognostic marker in endometrial cancer: A retrospective study.
Wang J; Zhang K; Liu Z; Wang T; Shi F; Zhang Y; Su J; Jia Y
Medicine (Baltimore); 2018 Dec; 97(51):e13442. PubMed ID: 30572444
[TBL] [Abstract][Full Text] [Related]
23. Determining breast cancer histological grade from RNA-sequencing data.
Wang M; Klevebring D; Lindberg J; Czene K; Grönberg H; Rantalainen M
Breast Cancer Res; 2016 May; 18(1):48. PubMed ID: 27165105
[TBL] [Abstract][Full Text] [Related]
24. NDUFA4L2 is a novel biomarker for colorectal cancer through bioinformatics analysis.
Lin Y; Xie H; Zhao W; Li Y; Zhang Z
Medicine (Baltimore); 2023 Nov; 102(44):e35893. PubMed ID: 37933010
[TBL] [Abstract][Full Text] [Related]
25. Increased Expression of POSTN Predicts Poor Prognosis: a Potential Therapeutic Target for Gastric Cancer.
Lu S; Peng L; Ma F; Chai J; Hua Y; Yang W; Zhang Z
J Gastrointest Surg; 2023 Feb; 27(2):233-249. PubMed ID: 36451060
[TBL] [Abstract][Full Text] [Related]
26. Sarcosine dehydrogenase as an immune infiltration-associated biomarker for the prognosis of hepatocellular carcinoma.
Xie H; Yang K; Qin C; Zhou X; Liu J; Nong J; Luo J; Wei Y; Hua H; Han C; Liao X; Yang C; Su H; Zhu G; Ye X; Peng T
J Cancer; 2024; 15(1):149-165. PubMed ID: 38164283
[TBL] [Abstract][Full Text] [Related]
27. Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis.
Wang Y; Kong Y; Yang Q; Zhong C; Zhou D
Eur J Med Res; 2024 Apr; 29(1):221. PubMed ID: 38581008
[TBL] [Abstract][Full Text] [Related]
28. Identification of
Zou J; Chen Y; Ji Z; Liu D; Chen X; Chen M; Chen K; Lin H; Chen Y; Li Z
Transl Cancer Res; 2024 Jan; 13(1):25-45. PubMed ID: 38410217
[TBL] [Abstract][Full Text] [Related]
29. Multi-omics Analysis Identifies Hypoxia Subtypes and S100A2 as an Immunosuppressive Factor in Cervical Cancer.
Yang J; Wan S; Zhao M; Cai H; Gao Y; Wang H
Reprod Sci; 2024 Jan; 31(1):107-121. PubMed ID: 37648942
[TBL] [Abstract][Full Text] [Related]
30. SLC25A11 serves as a novel prognostic biomarker in liver cancer.
Pan G; Wang R; Jia S; Li Y; Jiao Y; Liu N
Sci Rep; 2020 Jun; 10(1):9871. PubMed ID: 32555317
[TBL] [Abstract][Full Text] [Related]
31. Re-stratification of patients with copy-number low endometrial cancer by clinicopathological characteristics.
Liwei L; He L; Yibo D; Luyang Z; Zhihui S; Nan K; Danhua S; Junzhu W; Zhiqi W; Jianliu W
World J Surg Oncol; 2023 Oct; 21(1):332. PubMed ID: 37865800
[TBL] [Abstract][Full Text] [Related]
32. HNF1B polymorphism influences the prognosis of endometrial cancer patients: a cohort study.
Mandato VD; Farnetti E; Torricelli F; Abrate M; Casali B; Ciarlini G; Pirillo D; Gelli MC; Nicoli D; Grassi M; LA Sala GB; Palomba S
BMC Cancer; 2015 Apr; 15():229. PubMed ID: 25885815
[TBL] [Abstract][Full Text] [Related]
33. Elevated expression of TUBA1C in breast cancer predicts poor prognosis.
Zhao Y; Wang W; Li J; Du J; Xie Q; Wang M; Liu Z; Huo X; Zhao F; Ren D; Zhao J; Shen G
PLoS One; 2023; 18(11):e0263710. PubMed ID: 38032902
[TBL] [Abstract][Full Text] [Related]
34. Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells.
Lin X; Zheng J; Cai X; Liu L; Jiang S; Liu Q; Sun Y
BMC Cancer; 2024 May; 24(1):571. PubMed ID: 38720279
[TBL] [Abstract][Full Text] [Related]
35. CRABP2 - A novel biomarker for high-risk endometrial cancer.
Egan D; Moran B; Wilkinson M; Pinyol M; Guerra E; Gatius S; Matias-Guiu X; Kolch W; le Roux CW; Brennan DJ
Gynecol Oncol; 2022 Nov; 167(2):314-322. PubMed ID: 36163055
[TBL] [Abstract][Full Text] [Related]
36. Identification of a gene expression signature for survival prediction in type I endometrial carcinoma.
Levan K; Partheen K; Osterberg L; Olsson B; Delle U; Eklind S; Horvath G
Gene Expr; 2010; 14(6):361-70. PubMed ID: 20635577
[TBL] [Abstract][Full Text] [Related]
37. Novel miRNA markers for the diagnosis and prognosis of endometrial cancer.
Wang Q; Xu K; Tong Y; Dai X; Xu T; He D; Ying J
J Cell Mol Med; 2020 Apr; 24(8):4533-4546. PubMed ID: 32150330
[TBL] [Abstract][Full Text] [Related]
38. Exploring the prognostic value of S100A11 and its association with immune infiltration in breast cancer.
He J; Lei Y; Li X; Wu B; Tang Y
Sci Rep; 2023 Dec; 13(1):22922. PubMed ID: 38129538
[TBL] [Abstract][Full Text] [Related]
39. High RRM2 expression has poor prognosis in specific types of breast cancer.
Shi SC; Zhang Y; Wang T
PLoS One; 2022; 17(3):e0265195. PubMed ID: 35290409
[TBL] [Abstract][Full Text] [Related]
40. Upregulated expression of
He Y; Du Z; Peng H; Reddy AV; Cao P
J Gastrointest Oncol; 2024 Feb; 15(1):435-457. PubMed ID: 38482253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
